Several studies have validated the significance of HPSE as a valid anti-cancer drug target by demonstrating inhibition of human myeloma, lymphoma, glioma, sarcoma, mesothelioma and pancreatic tumor growth in mice treated with the heparin-like heparanase-inhibiting compounds Roneparstat and Pixatimod [269]. This evidence concerns the gene HPSE and cancer.